Biotie's Annual Financial Report and Corporate Governance Statement 2012 published
(Thomson Reuters ONE) -
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 7 March 2013 at 9.00 a.m.
Biotie's Annual Financial Report and Corporate Governance Statement 2012
published
Biotie Therapies Corp.' s Annual financial report for the financial period
ended 31 December 2012 as well as Corporate Governance Statement 2012 have been
published.
The documents are attached in pdf format in this release. Both documents are
also available at Biotie's website www.biotie.com in English and Finnish
language.
Turku, 7 March 2013
Biotie Therapies Corp.
Timo Veromaa
President and CEO
For further information, please contact:
Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900
e-mail: virve.nurmi(at)biotie.com
DISTRIBUTION
NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com
About Biotie
Biotie is a specialized drug development company focused on the development of
drugs for neurodegenerative and psychiatric disorders (e.g. Parkinson's disease,
Alzheimer's disease and other cognitive disorders, alcohol and drug dependence
(addiction) and post-traumatic stress disorder), and inflammatory and fibrotic
liver disease. The company has a strong and balanced development portfolio with
several innovative small molecule and biological drug candidates at different
stages of clinical development. Biotie's products address diseases with high
unmet medical need and significant market potential.
Biotie's most advanced product, Selincro(TM) (nalmefene), licensed to Lundbeck
A/S, has on 28 February 2013 received European marketing authorization for the
reduction of alcohol consumption in adult patients with alcohol dependence who
have a high level of alcohol consumption. In addition, Biotie has a strategic
collaboration with UCB Pharma S.A. covering tozadenant which is transitioning
into Phase 3 development,
Biotie shares are listed on NASDAQ OMX Helsinki Ltd.
Biotie_Financial statements 2012:
http://hugin.info/132030/R/1683596/551050.pdf
Biotie_Corporate Governance Statement 2012:
http://hugin.info/132030/R/1683596/551051.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biotie Therapies Oyj via Thomson Reuters ONE
[HUG#1683596]
Unternehmensinformation / Kurzprofil:
Datum: 07.03.2013 - 08:01 Uhr
Sprache: Deutsch
News-ID 236952
Anzahl Zeichen: 2933
contact information:
Town:
Turku
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 156 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Biotie's Annual Financial Report and Corporate Governance Statement 2012 published"
steht unter der journalistisch-redaktionellen Verantwortung von
Biotie Therapies Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
